| PERIOD ENDING | 30-Jun-08 | 31-Mar-08 | 31-Dec-07 | 30-Sep-07 | | Total Revenue | 1,930,000 | 2,311,000 | 1,940,000 | 2,250,000 | | Cost of Revenue | 278,000 | 399,000 | 493,000 | 511,000 | | | Gross Profit | 1,652,000 | 1,912,000 | 1,447,000 | 1,739,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 861,000 | 715,000 | 931,000 | 785,000 | | Non Recurring |
-
|
-
| (78,000) | 78,000 | | Others | 719,000 | 544,000 | 253,000 | 170,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 72,000 | 653,000 | 341,000 | 706,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 72,000 | 653,000 | 341,000 | 706,000 | | Interest Expense | 190,000 | 228,000 | 277,000 | 263,000 | | Income Before Tax | (118,000) | 425,000 | 64,000 | 443,000 | | Income Tax Expense | 84,000 | 139,000 | 47,000 | 119,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (202,000) | 286,000 | 17,000 | 324,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (202,000) | 286,000 | 17,000 | 324,000 | | Preferred Stock And Other Adjustments |
-
|
-
| (1,000) | 1,000 | | | Net Income Applicable To Common Shares | ($202,000) | $286,000 | $16,000 | $325,000 |
|
7.87% Nasdaq 
Income Statement
